Currently, Trxade Health Inc [MEDS] is trading at $32.72, up 28.16%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MEDS shares have gain 263.56% over the last week, with a monthly amount glided 686.54%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 6, March 2024, TRxADE Health, Inc. Announces Special Cash Dividend. In a post published today on Yahoo Finance, TRxADE HEALTH Inc. (Nasdaq: MEDS), announced that the Company’s board of directors has declared a special cash dividend of $8.00 per share of common stock. The special dividend is being paid using a portion of the proceeds from the closing of the recently announced sale of the Company’s web-based market platform assets. The special cash dividend is payable to stockholders of record as of March 18, 2024, with the dividend being paid on or about March 22, 2024.
From an analyst’s perspective:
This stock has fluctuated between a low of $3.69 and a high of $25.53 over the last 52 weeks. Trxade Health Inc [NASDAQ: MEDS] shares were valued at $32.72 at the most recent close of the market.
Analyzing the MEDS fundamentals
Trailing Twelve Months sales for Trxade Health Inc [NASDAQ:MEDS] were 9.09M which represents -14.26% decline. Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.42%, and Net Profit Margin reading is -0.81%. To continue investigating profitability, this company’s Return on Assets is posted at -0.34, Equity is -2.51 and Total Capital is -0.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.56.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 25.36 points at the first support level, and at 18.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 42.32, and for the 2nd resistance point, it is at 51.92.
Trxade Health Inc [MEDS] reported earnings per share of -$2.9 for its fiscal quarter that ended on 6/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.75/share, meaning a difference of -$2.15 and a surprise factor of -286.70%. By comparison, the stated earnings for the previous quarter ended on 3/30/2023 were -$0.45 per share as compared to estimates of -$0.45 per share, a difference of $0 representing a surprise of 0.00%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Trxade Health Inc [NASDAQ:MEDS] is 0.61. Also, the Quick Ratio is 0.28, while the Cash Ratio stands at 0.0. Considering the valuation of this stock, the price to sales ratio is 4.36, the price to book ratio is 2.32.
